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Abstract
Background: To evaluate whether the volume of blood suctioned during vacuum-assisted breast biopsy (VABB) is 
associated with hematoma formation and progression, patient's age and histology of the lesion.
Findings: 177 women underwent VABB according to standardized protocol. The volume of blood suctioned and 
hematoma formation were noted at the end of the procedure, as did the subsequent development and progression of 
hematoma. First- and second-order logistic regression was performed, where appropriate. Cases with hematoma 
presented with greater volume of blood suctioned (63.8 ± 44.7 cc vs. 17.2 ± 32.9 cc; p < 0.001, Mann-Whitney-Wilcoxon 
test for independent samples, MWW); the likelihood of hematoma formation was increasing till a volume equal to 82.6 
cc, at which the second-order approach predicts a maximum. The volume of blood suctioned was positively associated 
with the duration of the procedure (Spearman's rho = 0.417, p < 0.001); accordingly, hematoma formation was also 
positively associated with the latter (p = 0.004, MWW). The volume of blood suctioned was not associated with 
patients' age, menopausal status and histopathological diagnosis.
Conclusion: The likelihood of hematoma is increasing along with increasing amount of blood suctioned, reaching a 
plateau approximately at 80 cc of blood lost.
Findings
The use of stereotactic vacuum breast biopsy (VABB) is
increasing in clinical practice for the assessment of non-
palpable mammographic lesions [1-3]. Taking a larger
volume of tissue than a standard core biopsy, VABB
seems capable of "forgiving" minor targeting inaccuracies
[1-3]. That said, it is not without complication, its main
one being hematoma formation [1]. Given that VABB is
performed in the outpatient setting and women are dis-
charged within one hour after biopsy, the suspicion for
hematoma formation, as well as its progression, seems
crucial. Worthy to mention is that neither the volume of
blood suctioned and collected in the device's bin nor its
implications have ever been studied in detail.
The objective of this study is to evaluate whether the
volume of blood suctioned during VABB is associated
with hematoma formation and progression, patient's age
and histology of the lesion. To our knowledge, this is the
first study to evaluate the bleeding during VABB and its
implications.
Materials and methods
Study design, performance of VABB and follow-up of 
patients
This study enrolled 177 women with a median age of 51
(range 32-81) years, (mean ± SD: 52.4 ± 9.6), who under-
went VABB for non-palpable mammographic lesions (BI-
RADS 4). Exclusion criteria were: current use of aspirin
or non-steroid anti-inflammatory drugs, oral anticoagu-
lants, vitamin E, herbal supplements that may contribute
to bleeding and history of bleeding disorders. * Correspondence: gzografo@med.uoa.gr
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VABB was performed on the digital prone table (Mam-
motest, Fischer Imaging, Denver, CO, USA) using 11-
gauge Mammotome vacuum probes, under local anesthe-
sia, according to standardized protocol; 24-96 cores were
obtained, according to the results of a double blind study
[3]. All procedures were performed by the same surgeon,
in the same unit. For local anesthesia in VABB, the two-
step approach was adopted: 5 cm3 1% lidocaine without
epinephrine (superficial), and 10 cm3 1% lidocaine with
epinephrine (deep) were administered [4]. After VABB,
mammograms were obtained from the women's breast, as
well as from the specimens excised, confirming the suc-
cessful sampling of the suspicious lesion.
T he  vo lum e  o f  bl ood s uct io ned in t o  t he  devic e ' s  bin
was registered at the end of the procedure in all cases;
importantly, no rinsing saline fluid has been pushed into
the VABB probe, as this could have interfered with the
measured blood aspiration volume. Hematoma formation
was noted after the examination of all traditional mam-
mogram projections (CC, MLO) independently by two
radiologists (GG and DK). Compression bandages were
applied so as to prevent hematoma. In all cases, the
occurrence of clinically significant (i.e. subsequently
organized, diameter larger than 3 cm) hematomas within
the subsequent four weeks was followed up by ultrasound
and clinical examination of the breast.
Concerning the histopathological evaluation, the type
of the lesion was noted, i.e. benign lesion, precursor
lesion (atypical ductal hyperplasia or lobular neoplasia)
[5,6], carcinoma (in situ or invasive).
Statistical analysis
For the evaluation of the associations between the vol-
ume of blood suctioned/hematoma and the duration of
the procedure, age, menopausal status, and histopatho-
logical diagnosis, non-parametric tests, i.e. Mann-Whit-
ney-Wilcoxon test for independent samples (MWW) or
Spearman's rank correlation coefficient, were imple-
mented. This choice has been made given that non-para-
metric tests are appropriate for non-normal distributions
and that they are not heavily influenced by outliers, since
the tests allocate ranks to the observations
Focusing on the blood suctioned-hematoma associa-
tion, logistic regression was performed. Hematoma for-
mation, treated as a dichotomous variable (0: no, 1: yes),
was set as dependent variable, whereas the volume of
blood suctioned was set as independent variable. Higher-
order associations (second- and third-order were evalu-
ated).
Statistical analysis was performed with STATA 8.0 sta-
tistical software (Stata Corporation, College Station, TX,
USA).
Informed consent was obtained by all participants in
this study. This study has been approved by the local Eth-
ics Committee, in compliance to the Helsinki Declara-
tion.
Results
The features of the study population are depicted in Table
1. The volume of blood suctioned was positively associ-
ated with the duration of the procedure (Spearman's rho
= 0.417, p < 0.001); accordingly, hematoma formation was
also positively associated with the latter (p = 0.004,
MWW). However, the volume of blood suctioned was
not associated with patients' age, menopausal status and
histopathological diagnosis.
Concerning the association with hematoma formation,
cases with hematoma presented with greater volume of
blood suctioned (63.8 ± 44.7 cc vs. 17.2 ± 32.9 cc; p <
0.001, MWW). Interestingly, at the logistic regression
model with hematoma formation set as the dependent
variable, the association with the volume of blood suc-
tioned followed a second-order pattern, i.e.
Both coefficients of the first- and the second-order
term were statistically significant (p < 0.001). The above
equation yields a predicted maximum at the log-odds
scale corresponding to a volume equal to 82.6 cc.
Discussion
Hematoma formation is associated with greater amount
of blood suctioned during VABB. Of special interest, the
association between volume of blood lost and hematoma
formation follows a quadratic pattern. The probability of
hematoma formation seems increasing till a volume equal
to 82.6 cc, at which the second-order approach predicts a
maximum. Noticeably, the exact value at which the maxi-
m u m  has  bee n de mo nst r a t ed is r a t he r indi ca ti ve . A t a
clinical level, this may imply a plateau reached above
approx. 80 cc, where the hematoma probability has
already been maximized. Indeed, the surgeon should be
alert when this crucial domain is reached, as subsequent
hematoma formation may be imminent.
Another significant finding that was demonstrated by
our study concerns the duration of the procedure. Longer
duration is correlated with greater amount of blood lost
and hematoma formation. Longer duration may indicate
a more strenuous procedure, characterized by more
intense pain and greater blood loss [4].
A limitation of the study that needs to be declared per-
tains to the number of cores (24 to 96) excised; this is in
line with the "extended protocol" of a double-blind study
previously published by our team [3]. Indeed, the number
of cores seems considerably larger than that in the major-
ity of studies excising 6 to 12 cores [3]. Given that the
number of cores has not been analysed as a risk factor in
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this study, it should be kept in mind that the association
between the amount of blood suctioned and hematoma
ma y an indir ect one. In other words, lar ger volume of
blood suctioned or longer duration of the procedure may
be surrogate markers reflecting the effect of a greater
number of excised cores, the latter per se predicting
increased likelihood for hematoma formation.
To our knowledge, this is the first study that provides
insight into the implications of blood suctioned during
the procedure. Future studies adopting a quantitative
approach on the blood lost, along with other factors puta-
tively modulating the latter, such as depth of the lesion,
may provide valuable insight into the strenuousness,
adverse effects and complications of VABB.
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Table 1: Features of the study population
Continuous variables mean ± SD
Age (years) 51.5 ± 10.1
Duration of the procedure (min) 39.6 ± 14.6
Volume of tissue excised (cm3) 6.34 ± 2.87
Blood suctioned during the procedure (cc) 21.5 ± 36.6
Categorical and ordinal variables N Percentage
Menopausal status
Premenopausal 80 45.2%
Postmenopausal 97 54.8%
Histopathological diagnosis
Benign 116 65.5%
Precursor lesions & carcinomas 61 34.5%
Hematoma
No 161 91.0%
Yes 16 9.0%Zagouri et al. BMC Research Notes 2010, 3:70
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